​

Repligen (RGEN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Repligen Revenue Highlights

Latest Revenue (Y)

$634.44M

Latest Revenue (Q)

$141.19M

Main Segment (Y)

Product

Repligen Revenue by Period

Repligen Revenue by Year

DateRevenueChange
2024-12-31$634.44M0.33%
2023-12-31$632.36M-21.11%
2022-12-31$801.54M19.54%
2021-12-31$670.53M83.08%
2020-12-31$366.26M35.53%
2019-12-31$270.25M39.28%
2018-12-31$194.03M37.38%
2017-12-31$141.24M35.10%
2016-12-31$104.54M25.14%
2015-12-31$83.54M31.45%
2014-12-31$63.55M-6.78%
2013-12-31$68.17M9.48%
2012-12-31$62.27M128.16%
2011-03-31$27.29M30.14%
2010-03-31$20.97M-28.58%
2009-03-31$29.36M52.16%
2008-03-31$19.30M37.10%
2007-03-31$14.07M9.01%
2006-03-31$12.91M37.94%
2005-03-31$9.36M35.38%
2004-03-31$6.91M-11.03%
2003-03-31$7.77M80.67%
2002-03-31$4.30M83.30%
2001-03-31$2.35M-31.99%
2000-03-31$3.45M32.72%
1999-03-31$2.60M8.33%
1998-03-31$2.40M-36.84%
1997-03-31$3.80M-65.14%
1996-03-31$10.90M-35.50%
1995-03-31$16.90M-36.94%
1994-03-31$26.80M-1.83%
1993-03-31$27.30M-

Repligen generated $634.44M in revenue during NA 2024, up 0.33% compared to the previous quarter, and up 234.76% compared to the same period a year ago.

Repligen Revenue by Quarter

DateRevenueChange
2024-09-30$141.19M-8.36%
2024-06-30$154.07M1.80%
2024-03-31$151.35M-2.82%
2023-12-31$155.74M10.31%
2023-09-30$141.19M-11.29%
2023-06-30$159.17M-12.86%
2023-03-31$182.66M-2.20%
2022-12-31$186.76M-6.96%
2022-09-30$200.74M-3.32%
2022-06-30$207.63M0.60%
2022-03-31$206.40M10.66%
2021-12-31$186.52M4.66%
2021-09-30$178.22M9.36%
2021-06-30$162.96M14.09%
2021-03-31$142.84M31.47%
2020-12-31$108.65M15.51%
2020-09-30$94.06M7.54%
2020-06-30$87.46M14.95%
2020-03-31$76.09M9.52%
2019-12-31$69.47M0.04%
2019-09-30$69.44M-1.76%
2019-06-30$70.69M16.59%
2019-03-31$60.63M16.73%
2018-12-31$51.94M4.87%
2018-09-30$49.53M3.77%
2018-06-30$47.73M6.47%
2018-03-31$44.83M7.74%
2017-12-31$41.61M13.75%
2017-09-30$36.58M12.71%
2017-06-30$32.45M6.10%
2017-03-31$30.59M19.50%
2016-12-31$25.60M3.74%
2016-09-30$24.68M-15.40%
2016-06-30$29.17M16.24%
2016-03-31$25.09M16.99%
2015-12-31$21.45M8.25%
2015-09-30$19.81M-7.66%
2015-06-30$21.46M3.08%
2015-03-31$20.82M26.98%
2014-12-31$16.39M7.30%
2014-09-30$15.28M-1.75%
2014-06-30$15.55M-4.75%
2014-03-31$16.33M6.13%
2013-12-31$15.38M-18.27%
2013-09-30$18.82M7.50%
2013-06-30$17.51M6.40%
2013-03-31$16.46M-12.53%
2012-12-31$18.81M24.56%
2012-09-30$15.10M-2.70%
2012-06-30$15.52M21.05%
2012-03-31$12.82M48.58%
2011-09-30$8.63M12.77%
2011-06-30$7.65M29.58%
2011-03-31$5.91M-16.43%
2010-12-31$7.07M-3.27%
2010-09-30$7.31M4.24%
2010-06-30$7.01M43.87%
2010-03-31$4.87M-13.26%
2009-12-31$5.62M3.63%
2009-09-30$5.42M7.11%
2009-06-30$5.06M10.17%
2009-03-31$4.59M-23.66%
2008-12-31$6.02M18.23%
2008-09-30$5.09M-62.74%
2008-06-30$13.66M313.85%
2008-03-31$3.30M-

Repligen generated $141.19M in revenue during Q3 2024, up -8.36% compared to the previous quarter, and up 88.71% compared to the same period a year ago.

Repligen Revenue Breakdown

Repligen Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Filtration Products$372.96M$347.78M$495.93M$403.50M$174.90M
Process Analytics Products$59.30M$56.82M$53.51M$48.02M$33.35M
Product$634.18M$638.38M$801.18M$670.32M$366.14M
Proteins Products$74.42M$103.46M$114.32M$123.71M$80.73M
Other products$4.68M$3.69M$5.74M$4.05M$3.61M
Chromatography Products$122.81M$126.63M$131.68M$91.04M$73.55M

Repligen's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (50.00%), Filtration Products (29.41%), Chromatography Products (9.68%), Proteins Products (5.87%), Process Analytics Products (4.68%), and Other products (0.37%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Product$174.00M$154.83M$154.04M$151.31M$155.47M$141.16M$159.13M$182.62M$186.51M$200.71M$207.60M$206.36M$186.49M$178.18M$162.92M$142.74M$108.61M$94.03M$87.43M$76.06M
Royalty-$37.00K$35.00K$36.00K$36.00K$36.00K$39.00K$247.00K$33.00K$36.00K$37.00K$36.00K$39.00K$40.00K$100.00K$33.00K$31.00K$30.00K$30.00K-

Repligen's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (100.00%).

Repligen Revenue Breakdown by Country

Quarterly Revenue by Country

CountrySep 18Jun 18Mar 18
All Other$62.00K$55.00K$243.00K
North America$24.06M$22.48M$20.24M
Europe$19.33M$19.58M$19.40M
Asia and Australia$6.08M$5.62M-
Asia Pacific--$4.95M

Repligen's latest quarterly revenue breakdown by geography, as of Sep 18: North America (48.59%), Europe (39.02%), Asia and Australia (12.27%), and All Other (0.13%).

Repligen Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and$20.18B$5.17B
ISRGIntuitive Surgical$8.35B$2.04B
RMDResMed$4.69B$1.22B
HOLXHologic$4.03B$1.02B
COOCooper Companies$3.90B$964.70M
ATRAptarGroup$3.58B$909.29M
TFXTeleflex$3.05B$764.38M
WSTWest Pharmaceutical Services$2.89B$746.90M
ICUIICU Medical$2.38B$589.13M
HAEHaemonetics$1.31B$348.54M
MMSIMerit Medical Systems$1.30B$339.85M
RGENRepligen$634.44M$141.19M
ANGOAngioDynamics$303.91M$72.00M
NVSTEnvista-$884.70M

RGEN Revenue FAQ

What is Repligen’s yearly revenue?

Repligen's yearly revenue for 2024 was $634.44M, representing an increase of 0.33% compared to 2023. The company's yearly revenue for 2023 was $632.36M, representing a decrease of -21.11% compared to 2022. RGEN's yearly revenue for 2022 was $801.54M, representing an increase of 19.54% compared to 2021.

What is Repligen’s quarterly revenue?

Repligen's quarterly revenue for Q3 2024 was $141.19M, a -8.36% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $154.07M, a 1.80% increase from the previous quarter (Q1 2024), and a -3.20% decrease year-over-year (Q2 2023). RGEN's quarterly revenue for Q1 2024 was $151.35M, a -2.82% decrease from the previous quarter (Q4 2023), and a -17.14% decrease year-over-year (Q1 2023).

What is Repligen’s revenue growth rate?

Repligen's revenue growth rate for the last 3 years (2022-2024) was -20.85%, and for the last 5 years (2020-2024) was 73.22%.

What are Repligen’s revenue streams?

Repligen's revenue streams in c 24 are Filtration Products, Process Analytics Products, Product, Proteins Products, Other products, and Chromatography Products. Filtration Products generated $372.96M in revenue, accounting 29.41% of the company's total revenue, up 7.24% year-over-year. Process Analytics Products generated $59.3M in revenue, accounting 4.68% of the company's total revenue, up 4.37% year-over-year. Product generated $634.18M in revenue, accounting 50.00% of the company's total revenue, down -0.66% year-over-year. Proteins Products generated $74.42M in revenue, accounting 5.87% of the company's total revenue, down -28.07% year-over-year. Other products generated $4.68M in revenue, accounting 0.37% of the company's total revenue, up 26.87% year-over-year. Chromatography Products generated $122.81M in revenue, accounting 9.68% of the company's total revenue, down -3.02% year-over-year.

What is Repligen’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Repligen was Product. This segment made a revenue of $634.18M, representing 50.00% of the company's total revenue.